Company intelligence / Profile preview

OneCell Diagnostics

Foster City, California, United States

Ownership: Private
Employees: ~140
Development stage: Other

Overview

OneCell Diagnostics has commercially deployed its proprietary liquid "cell biopsy" tests in India for recurrence monitoring and precision oncology decision support across solid tumors, and is expanding to the U.S. with CLIA-certified lab capabilities and multi-omic biomarker panels to support clinical care and early-stage oncology trials.[3][5][1]

Therapeutic areas: Oncology
Modalities: DeviceDiagnostic assay
Industry: Molecular Diagnostics

Partnerships

All India Institute of Medical Sciences (AIIMS), New DelhiTata Memorial CentreApollo HospitalsFortis HealthcareHarvard Medical SchoolStanford UniversityMedical College of Georgia at Augusta UniversityBiotech and biopharma companies using OncoIndx Ikon / OncoIncytes for early-stage clinical trials

Beyond the preview

Go deeper on OneCell Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OneCell Diagnostics.

Explore the full profile